US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Quasi-New Stocks

675.33

-5.9418-0.87%

Number of Gainers:54

Number of Losers:89

Number of Flat:10

PE:- -

High:688.68

Open:681.40

Low:674.19

Close:681.27

Volume:431.58M

Turnover:8.23B

Market Cap:466.28B

Float Cap:358.72B

Loading ...

Valerio Therapeutics accelerates RNA precision pivot with Etherna deal and new CEO

Levi Strauss, Constellation Brands and 3 Stocks to Watch Heading Into Wednesday

Benzinga Earnings

Should New FILSPARI Data Require Action From Travere Therapeutics Stock Investors?

Simply Wall St.

Press Release: Valerio Therapeutics Provides an Update on Its Business and Presents Its Financial Results for the First Half of 2026

Equativ Partners with DoubleVerify to Add Media Quality Verification to SSP

Percheron Therapeutics Wins Strong Shareholder Backing at 2026 AGM

Coinbase Says at the End of This Year, Coinbase Pro is Coming Back to Serve as the Professional-Grade Platform for Trading Spot, Futures, Perpetuals

Coinbase - Coinbase Financial Markets Will Soon Connect US and Global Crypto Derivatives into a Single Regulated Liquidity Pool

THOMSON REUTERS

Coinbase CEO: Coinbase Pro is Coming Back

THOMSON REUTERS

Caribou Biosciences, Inc. : Leerink Partners Cuts to Market Perform from Outperform; Cuts Target Price to $1 from $4

THOMSON REUTERS

Arovella Therapeutics Says Second Clinical Batch of ALA-101 Manufactured and Released

MT Newswires Live

BAB And 2 Other Penny Stocks To Watch

Simply Wall St.

Allied Farmers Sets November Date for Hybrid AGM and Board Appointment Vote

SentinelOne CEO Tomer Weingarten Disposes of 527,368 Shares Worth $13.32 Million

Stocks to Watch: Constellation, Caribou, Penguin

Mobix Labs Targets Expansion into US Rare Earth, Critical Minerals Markets Via NSM Platform

Press Release: Mobix Labs to Host Investor Update Call on Critical Minerals Strategy and Business Outlook

Nuo Therapeutics Secures Second Loan Funding with Warrants

Caribou Falls After Scrapping Cell Therapy Programs, Launches Strategic Review

Caribou Biosciences to End Drug Development, Cut Staff Due to Funding Problems

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sgp.itiger.com/stock/BK4539/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4539","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","market":"US","secType":"PLATE","nameCN":"Quasi-New Stocks","latestPrice":675.3264,"timestamp":1791316799999,"preClose":681.2682,"halted":0,"volume":431582928,"delay":0,"changeRate":-0.008722,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":-5.941772,"latestTime":"10-06 16:00:00 EDT","open":681.3977,"high":688.67615,"low":674.186,"amount":8227515564.490718,"amplitude":0.021269,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1791379800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":5.235408,"peRate":115.607072,"turnoverRate":0.033838,"increases":54,"decrements":89,"flats":7,"marketCap":466275742368,"floatMarketCap":358720535770.125},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","high":688.67615,"amplitude":0.021269,"preClose":681.2682,"low":674.186,"pbRate":"5.235408","latestPrice":675.3264,"volume":431582928,"delay":0,"open":681.3977,"prevYearClose":881.5255,"prevWeekClose":665.7447,"prevMonthClose":677.2829,"prevQuarterClose":677.2829,"fiveDayClose":687.6132,"twentyDayClose":705.7056,"sixtyDayClose":736.402,"secType":"PLATE","market":"US","turnoverRate":0.033838,"peRate":115.607072,"marketCap":466275742368,"floatMarketCap":358720535770.125,"timestamp":1791316799999,"nameCN":"Quasi-New Stocks"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4539\",,,,undefined,":{"bkCode":"BK4539","up":54,"down":89,"flat":10},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4539\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2673095666","title":"Valerio Therapeutics accelerates RNA precision pivot with Etherna deal and new CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2673095666","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673095666?lang=en_us&edition=fundamental","pubTime":"2026-10-07 15:08","pubTimestamp":1791356913,"startTime":"0","endTime":"0","summary":"Valerio Therapeutics ( ($FR:ALVIO) ) just unveiled an announcement. Valerio Therapeutics reported that the first half of 2026 was pivotal in its st...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/valerio-therapeutics-accelerates-rna-precision-pivot-with-etherna-deal-and-new-ceo?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/valerio-therapeutics-accelerates-rna-precision-pivot-with-etherna-deal-and-new-ceo?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4139","BK4539","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673093869","title":"Levi Strauss, Constellation Brands and 3 Stocks to Watch Heading Into Wednesday","url":"https://stock-news.laohu8.com/highlight/detail?id=2673093869","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673093869?lang=en_us&edition=fundamental","pubTime":"2026-10-07 14:27","pubTimestamp":1791354435,"startTime":"0","endTime":"0","summary":"Stocks in focus: Levi Strauss and Applied Digital report earnings; Caribou halts programs; Constellation raises guidance; Richardson reports.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"11c8fbbf839f433c9d274cef5f173382","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/trading-ideas/long-ideas/26/10/62208995/levi-strauss-constellation-brands-and-3-stocks-to-watch-heading-into-wednesday","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4609","BK4116","BK4585","BK4202","BK4559","LU2552382058.USD","LU0757428866.USD","RELL","APLX","IBLC","CRBU","BK4169","LEVI","LU2552382215.SGD","DAPP","BK4588","BK4608","MNRS","LU2552382132.HKD","BK4539","BK4023","STZ","LU1815336091.USD","FDIG","BK4504","APLD","BK4140","APLZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673498095","title":"Should New FILSPARI Data Require Action From Travere Therapeutics Stock Investors?","url":"https://stock-news.laohu8.com/highlight/detail?id=2673498095","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673498095?lang=en_us&edition=fundamental","pubTime":"2026-10-07 14:23","pubTimestamp":1791354237,"startTime":"0","endTime":"0","summary":"Travere Therapeutics reported new FILSPARI data at ASN Kidney Week 2026, with SPARTAN, DUPLEX and PROTECT results underscoring efficacy, renal protection signals and safety in IgA nephropathy and FSGS, alongside real world and molecular findings.\nThe USPTO Notice of Allowance for a new FSGS use patent and an issued IgAN patent extend FILSPARI method-of-use protection into 2037, which matters for Travere Therapeutics’ pricing power, competitive position and long term planning around its lead...","market":"sg","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice2-card/1788928698944","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice2-card/1788928698944"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-tvtx/travere-therapeutics/news/should-new-filspari-data-require-action-from-travere-therape","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-tvtx/travere-therapeutics/news/should-new-filspari-data-require-action-from-travere-therape","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4211","ISBC","LENZ","TVTX","FFTY","BK4139","BK4539","BK4007","LU2324357040.USD","LFSC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673009802","title":"Press Release: Valerio Therapeutics Provides an Update on Its Business and Presents Its Financial Results for the First Half of 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2673009802","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673009802?lang=en_us&edition=fundamental","pubTime":"2026-10-07 14:21","pubTimestamp":1791354060,"startTime":"0","endTime":"0","summary":"--  Operational launch of InVimmune, a subsidiary dedicated to. differentiated approaches to in vivo cell therapy, with a first. --  Appointment of Gilles Besin as Chief Executive Officer, effective July. --  Signing of a binding term sheet with Abivax with a view to an exclusive. --  Achievement of a major strategic milestone with the acquisition of. Etherna Immunotherapies NV; the transaction is expected to be finalised. --  Cash and cash equivalents totaling EUR656,000 as at 30 June 2026. As of. the date of the half-year financier report, the cash position covers 12","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4539","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673709876","title":"Equativ Partners with DoubleVerify to Add Media Quality Verification to SSP","url":"https://stock-news.laohu8.com/highlight/detail?id=2673709876","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673709876?lang=en_us&edition=fundamental","pubTime":"2026-10-07 14:18","pubTimestamp":1791353921,"startTime":"0","endTime":"0","summary":"Equativ partners with DoubleVerify to add media quality verification to SSPEquativ entered a strategic integration partnership with DoubleVerify to embed media-quality verification directly into its S","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261007:nNDL8P1Jqc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DV","BK4009","BK4023","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673306057","title":"Percheron Therapeutics Wins Strong Shareholder Backing at 2026 AGM","url":"https://stock-news.laohu8.com/highlight/detail?id=2673306057","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673306057?lang=en_us&edition=fundamental","pubTime":"2026-10-07 12:57","pubTimestamp":1791349038,"startTime":"0","endTime":"0","summary":"Percheron Therapeutics ( ($AU:PER) ) has issued an update. Percheron Therapeutics Limited has reported the outcomes of its 2026 Annual General Meet...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/percheron-therapeutics-wins-strong-shareholder-backing-at-2026-agm?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/percheron-therapeutics-wins-strong-shareholder-backing-at-2026-agm?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4007","LENZ","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673673160","title":"Coinbase Says at the End of This Year, Coinbase Pro is Coming Back to Serve as the Professional-Grade Platform for Trading Spot, Futures, Perpetuals","url":"https://stock-news.laohu8.com/highlight/detail?id=2673673160","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673673160?lang=en_us&edition=fundamental","pubTime":"2026-10-07 11:42","pubTimestamp":1791344541,"startTime":"0","endTime":"0","summary":"BRIEF-Coinbase Says At The End Of This Year, Coinbase Pro Is Coming Back To Serve As The Professional-Grade Platform For Trading Spot, Futures, PerpetualsOct 6 (Reuters)-Coinbase Global IncCOIN.O:COIN","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261007:nFWN45S1J0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DAPP","BK4588","BK4600","IBLC","LU1861558580.USD","FDIG","LU1861217088.USD","FIAT","CONY","CONL","BK4551","COIO","LU1861220207.SGD","BLCK","BK4596","FINX","CONX","COIG","09311","07311","09711","ICOI","BK4112","COYY","COIW","LU2360107671.USD","COII","BK4535","BK4539","BK4585","CRPT","COIA","COIX","CONI","BK4595","BK4516","BKCH","LU1861559042.SGD","07711","BK4554","BITQ","COIN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673673850","title":"Coinbase - Coinbase Financial Markets Will Soon Connect US and Global Crypto Derivatives into a Single Regulated Liquidity Pool","url":"https://stock-news.laohu8.com/highlight/detail?id=2673673850","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673673850?lang=en_us&edition=fundamental","pubTime":"2026-10-07 11:39","pubTimestamp":1791344376,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261007:nFWN45S1J0:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["DAPP","COIA","BK4112","CONI","LU2360107671.USD","COIN","CONX","FIAT","BLCK","BK4539","COIG","09311","FINX","FDIG","BITQ","BK4554","LU1861217088.USD","LU1861559042.SGD","COIW","ICOI","COIX","COIO","BK4600","BKCH","LU1861220207.SGD","BK4588","CONY","COII","CONL","BK4595","BK4596","BK4551","LU1861558580.USD","COYY","BK4585","BK4516","07311","CRPT","BK4535","09711","07711","IBLC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673062700","title":"Coinbase CEO: Coinbase Pro is Coming Back","url":"https://stock-news.laohu8.com/highlight/detail?id=2673062700","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673062700?lang=en_us&edition=fundamental","pubTime":"2026-10-07 11:29","pubTimestamp":1791343761,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261007:nFWN45S20G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["COIX","09311","BKCH","COII","CONX","07311","BK4539","CRPT","LU1861558580.USD","LU2360107671.USD","BK4551","COIG","BK4585","COIO","BITQ","09711","COIN","FDIG","BK4595","FINX","IBLC","LU1861220207.SGD","BK4596","07711","CONY","DAPP","BLCK","COIA","BK4588","BK4112","BK4554","BK4516","BK4535","CONL","BK4600","COIW","COYY","CONI","FIAT","ICOI","LU1861217088.USD","LU1861559042.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673307062","title":"Caribou Biosciences, Inc. : Leerink Partners Cuts to Market Perform from Outperform; Cuts Target Price to $1 from $4","url":"https://stock-news.laohu8.com/highlight/detail?id=2673307062","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673307062?lang=en_us&edition=fundamental","pubTime":"2026-10-07 10:36","pubTimestamp":1791340581,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261007:nFWN45S1V0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CRBU","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673062351","title":"Arovella Therapeutics Says Second Clinical Batch of ALA-101 Manufactured and Released","url":"https://stock-news.laohu8.com/highlight/detail?id=2673062351","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673062351?lang=en_us&edition=fundamental","pubTime":"2026-10-07 10:29","pubTimestamp":1791340181,"startTime":"0","endTime":"0","summary":"Arovella Therapeutics  said a second clinical batch of ALA-101, its cell therapy for blood cancers, has been manufactured and released, according to a Wednesday filing on the Australian bourse.The company added that a third batch, which it expects to release by the end of December, is anticipated to provide enough material to complete the phase 1 trial of 46 patients across five hospital sites.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","LABX","BK4139","BK4539","LENZ","BK7096","ALA","ALA.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673067883","title":"BAB And 2 Other Penny Stocks To Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2673067883","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673067883?lang=en_us&edition=fundamental","pubTime":"2026-10-07 10:24","pubTimestamp":1791339892,"startTime":"0","endTime":"0","summary":"With the S&P 500 hitting a record high on the back of AI related stocks, many investors feel late to the party and worry most of the gains are already priced into the giants. That is where financially solid low priced shares can help. This article looks at three financially fitter penny stocks under US$5 that combine smaller size with stronger balance sheets so you can explore potential opportunities without only chasing the biggest tickers.\nThe three financially fit penny stocks highlighted...","market":"hk","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/4214000-choice1-card/1789016022172","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/4214000-choice1-card/1789016022172"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/consumer-services/otc-babb/bab/news/bab-and-2-other-penny-stocks-to-watch","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/consumer-services/otc-babb/bab/news/bab-and-2-other-penny-stocks-to-watch","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4585","BK4122","BK4076","AIPO","BK4526","BK4508","BK4077","BK4209","BK4502","BK4503","BK4513","BK4531","BK4539","BK4588","RERE","BK4532","MOMO","BABB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673906457","title":"Allied Farmers Sets November Date for Hybrid AGM and Board Appointment Vote","url":"https://stock-news.laohu8.com/highlight/detail?id=2673906457","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673906457?lang=en_us&edition=fundamental","pubTime":"2026-10-07 09:17","pubTimestamp":1791335851,"startTime":"0","endTime":"0","summary":"Allied Farmers Limited ( ($NZ:ALF) ) has issued an update. Allied Farmers Limited has called its 2026 annual meeting of shareholders for 19 Novembe...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/allied-farmers-sets-november-date-for-hybrid-agm-and-board-appointment-vote?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/allied-farmers-sets-november-date-for-hybrid-agm-and-board-appointment-vote?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4023","ALF","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673069557","title":"SentinelOne CEO Tomer Weingarten Disposes of 527,368 Shares Worth $13.32 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2673069557","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673069557?lang=en_us&edition=fundamental","pubTime":"2026-10-07 07:08","pubTimestamp":1791328089,"startTime":"0","endTime":"0","summary":"SentinelOne CEO Tomer Weingarten disposes of 527,368 shares worth $13.32 millionSentinelOne President, CEO, Director Tomer Weingarten sold 527,368 Class A shares on Oct. 5, 2026 at USD 25.2642.He conv","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261006:nNDL3sp06w:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"SentinelOne CEO Tomer Weingarten Disposes of 527,368 Shares Worth $13.32 Million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["S","LU2286300806.USD","BK4561","BK4588","BK4097","BK4585","BK4539","BK4560"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673069552","title":"Stocks to Watch: Constellation, Caribou, Penguin","url":"https://stock-news.laohu8.com/highlight/detail?id=2673069552","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673069552?lang=en_us&edition=fundamental","pubTime":"2026-10-07 07:04","pubTimestamp":1791327840,"startTime":"0","endTime":"0","summary":"Constellation Brands announced the acquisition of SpikedAde. Shares declined 4.5% to $115.67 in after-hours trading Tuesday.Caribou Biosciences said it was halting development on some products, cutting staff and initiating a strategic alternatives review after running into funding problems. The stock shed 34% to 75 cents after the bell.Penguin Solutions logged higher profit in the latest quarter driven by AI demand. Shares rose 6% to $68 in late trading.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4169","LU2552382132.HKD","HBMX","LU2552382058.USD","BK4539","CRBU","BK4585","IE00B19Z4B17.USD","BK4588","IE00B7SZL793.SGD","PENG","OPTZ","IE00B66KJ199.SGD","BK4559","BK4141","IE0031619046.USD","STZ","BK4139","LU2552382215.SGD","PENU","BK4504"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673669030","title":"Mobix Labs Targets Expansion into US Rare Earth, Critical Minerals Markets Via NSM Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2673669030","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673669030?lang=en_us&edition=fundamental","pubTime":"2026-10-07 06:03","pubTimestamp":1791324199,"startTime":"0","endTime":"0","summary":"Mobix Labs targets expansion into US rare earth, critical minerals markets via NSM platformMobix Labs set an Oct. 8, 2026 investor call to outline plans to expand into U.S. rare earths and critical mi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261006:nNDL4sFwBz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MOBX","BK4539","BK4141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673181066","title":"Press Release: Mobix Labs to Host Investor Update Call on Critical Minerals Strategy and Business Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2673181066","media":"Dow Jones","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673181066?lang=en_us&edition=fundamental","pubTime":"2026-10-07 06:03","pubTimestamp":1791324180,"startTime":"0","endTime":"0","summary":"--  Replay: Available on the Mobix Labs Investor Relations website for 12","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4141","FXZ","MTX","REMX","MOBX","MVPS","SPD","BK4109","BK4539","WEPN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673706503","title":"Nuo Therapeutics Secures Second Loan Funding with Warrants","url":"https://stock-news.laohu8.com/highlight/detail?id=2673706503","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673706503?lang=en_us&edition=fundamental","pubTime":"2026-10-07 05:18","pubTimestamp":1791321514,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Nuo Therapeutics ( ($AURX) ). On October 6, 2026, Nuo Therapeutics, Inc. completed the second funding under its...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/nuo-therapeutics-secures-second-loan-funding-with-warrants?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/nuo-therapeutics-secures-second-loan-funding-with-warrants?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4007","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673306593","title":"Caribou Falls After Scrapping Cell Therapy Programs, Launches Strategic Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2673306593","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673306593?lang=en_us&edition=fundamental","pubTime":"2026-10-07 04:52","pubTimestamp":1791319934,"startTime":"0","endTime":"0","summary":"BUZZ-Caribou falls after scrapping cell therapy programs, launches strategic review** Shares of biotech firm Caribou BiosciencesCRBU.Ofall 36.1% to $0.73 in extended trading** Co says it is exploring ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261006:nL4N45S1FS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","CRBU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673525065","title":"Caribou Biosciences to End Drug Development, Cut Staff Due to Funding Problems","url":"https://stock-news.laohu8.com/highlight/detail?id=2673525065","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673525065?lang=en_us&edition=fundamental","pubTime":"2026-10-07 04:37","pubTimestamp":1791319020,"startTime":"0","endTime":"0","summary":"Caribou Biosciences is exploring strategic alternatives and cutting jobs after it decided to discontinue the development of two of its cancer products.The biopharmaceutical company said Tuesday it wou","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CRBU","BK4539"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":41,"pageCount":1,"totalSize":803,"code":"91000000","status":"200"}]}}